C/EBPβ是IFN-α诱导慢性髓性白血病干细胞耗竭的关键介质
在ABL酪氨酸激酶抑制剂时代,彻底治愈慢性髓性白血病(CML)仍需清除CML干细胞。本研究发现IFN-α通过STAT1和STAT5激活,结合Cebpb新鉴定的3'远端增强子中的串联IFN-γ激活位点,上调C/EBPβ;抑制或删除这些位点可消除IFN-α依赖的C/EBPβ上调。IFN-α以C/EBPβ依赖方式在体内外诱导CML干细胞分化和耗竭,并在CML患者谱系阴性CD34+细胞中上调C/EBPβ并诱导耗竭。
要点
- IFN-α通过STAT1/STAT5结合Cebpb的3'远端增强子中的IFN-γ激活位点上调C/EBPβ。
- 抑制或删除IFN-γ激活位点可消除IFN-α依赖的C/EBPβ上调。
- IFN-α以C/EBPβ依赖方式在体内外诱导CML干细胞分化和耗竭。
核心结论
- C/EBPβ是IFN-α诱导CML干细胞分化和耗竭的关键介质。
研究设计与样本
- 使用表达BCR-ABL的小鼠细胞和CML患者谱系阴性CD34+细胞进行体外和体内研究。
主要发现
- IFN-α通过激活STAT1和STAT5,使其招募至Cebpb新鉴定的3'远端增强子中串联排列的IFN-γ激活位点,从而上调C/EBPβ。
- 抑制或删除IFN-γ激活位点可消除IFN-α依赖的C/EBPβ上调。
- IFN-α以C/EBPβ依赖方式在体外和体内诱导CML干细胞分化和耗竭。
- IFN-α在CML患者谱系阴性CD34+细胞中上调C/EBPβ并诱导耗竭。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Even in the era of ABL tyrosine kinase inhibitors, eradication of chronic myeloid leukemia (CML) stem cells is necessary for complete cure of the disease. Interferon-α (IFN-α) has long been used for the treatment of chronic-phase CML, but its mechanisms of action against CML stem cells remain unclear. We found that IFN-α upregulated CCAAT/enhancer binding protein β (C/EBPβ) in BCR-ABL-expressing mouse cells by activating STAT1 and STAT5, which were recruited to a newly identified 3' distal enhancer of Cebpb that contains tandemly aligned IFN-γ-activated site elements. Suppression or deletion of the IFN-γ-activated site elements abrogated IFN-α-dependent upregulation of C/EBPβ. IFN-α induced differentiation and exhaustion of CML stem cells, both in vitro and in vivo, in a C/EBPβ-dependent manner. In addition, IFN-α upregulated C/EBPβ and induced exhaustion of lineage- CD34+ cells from CML patients. Collectively, these results clearly indicate that C/EBPβ is a critical mediator of IFN-α-induced differentiation and exhaustion of CML stem cells.
引用
- Yokota A, Hirai H, Sato R, et al. C/EBPβ is a critical mediator of IFN-α-induced exhaustion of chronic myeloid leukemia stem cells. Blood Adv. 2019. PMID: 30755436. doi:10.1182/bloodadvances.2018020503
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。